ArticleFrontiers in oncology2022

Value of CT-Based Radiomics in Predicating the Efficacy of Anti-HER2 Therapy for Patients With Liver Metastases From Breast Cancer.

Miao He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.